Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vickers

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coliDavid M Livermore, Shazad Mushtaq, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamasesShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
<i>In Vitro</i> Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative BacteriaShazad Mushtaq, Zahra Sadouki, Anna Vickers, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2018
Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative BacteriaAnna Vickers, Shazad Mushtaq, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2022
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilutionShazad Mushtaq, Anna Vickers, Aiysha Chaudhry, et al.
International Journal of Antimicrobial Agents|March 15, 2021
Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteriaShazad Mushtaq, Paolo Garello, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2017
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteriaDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2021
Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing EnterobacteralesShazad Mushtaq, Anna Vickers, Nicholas Ellaby, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2021
Activity of cefepime/zidebactam (WCK 5222) against 'problem' antibiotic-resistant Gram-negative bacteria sent to a national reference laboratoryShazad Mushtaq, Paolo Garello, Anna Vickers, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coliDavid M Livermore, Shazad Mushtaq, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2017
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamasesShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
<i>In Vitro</i> Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative BacteriaShazad Mushtaq, Zahra Sadouki, Anna Vickers, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2018
Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative BacteriaAnna Vickers, Shazad Mushtaq, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2022
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilutionShazad Mushtaq, Anna Vickers, Aiysha Chaudhry, et al.
International Journal of Antimicrobial Agents|March 15, 2021
Cefepime/tazobactam compared with other tazobactam combinations against problem Gram-negative bacteriaShazad Mushtaq, Paolo Garello, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2017
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteriaDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|September 27, 2021
Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing EnterobacteralesShazad Mushtaq, Anna Vickers, Nicholas Ellaby, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2021
Activity of cefepime/zidebactam (WCK 5222) against 'problem' antibiotic-resistant Gram-negative bacteria sent to a national reference laboratoryShazad Mushtaq, Paolo Garello, Anna Vickers, et al.
Pageof 3